NCT05631249View on ClinicalTrials.gov

Sotorasib in Previously Treated Locally Advanced or Metastatic NSCLC Subjects With Mutated KRAS p.G12C

PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 13, 2022

Primary Completion Date

December 12, 2027

Study Completion Date

December 12, 2027

Conditions
KRAS P.G12CNon Small Cell Lung Cancer
Interventions
DRUG

Sotorasib 120Mg Tab

Daily sotorasib treatment until progression, unacceptable toxicity, death, or lost to follow-up

Trial Locations (5)

13015

RECRUITING

AP-HM Hôpital Nord, Marseille

69373

RECRUITING

Centre Léon Bérard, Lyon

75014

RECRUITING

Hôpital Paris Saint Joseph, Paris

75020

NOT_YET_RECRUITING

AP-HP Hôpital Tenon, Paris

94800

RECRUITING

Gustave Roussy, Villejuif

All Listed Sponsors
lead

Gustave Roussy, Cancer Campus, Grand Paris

OTHER